Healthcare & Pharmaceuticals
U.S. corporations gave away $18.15 billion in charitable donations in 2012 - a combination of cash, grants, and in-kind goods - up 12.2 percent in nominal terms over the previous year. A closer look reveals profit motives, notably for pharmaceutical companies and retail chain Wal-Mart.
A Swiss drug company, Novartis, will go before the Indian Supreme Court this monnth to fight patent laws that protect the global supply of inexpensive medicines to treat AIDS, cancer and other diseases. The lawsuit - which involves a drug called Gleevec - is being opposed by international aid groups.
The HRT (Hormone Replacement Therapy) scandal is bigger than most think. It's not just about menopausal women, like me, getting bad information from their physicians and the pharmaceutical industry for over 40 years, while the federal government stood by and did nothing. The scandal is much bigger than that.
International drugs companies should seek to reduce prices for medicines sold to the poorest countries and avoid filing for patent protection there, a report prepared for the World Health Organisation (WHO) said on Monday.
GlaxoSmithKline provides research funding to doctors who write favorable opinions of depression drugs for children, despite evidence from clinical trials that the medication can cause anger and even suicide.
DaVita, a company that provides health care to patients with kidney problems, has agreed to pay $495 million to settle whistleblower complaints that the company conspired to overcharge the U.S. government. This is in addition to the $400 million that the company had to pay out last year.
Should lobbyists for biotech and food companies make the rules on what kind of food you have in your kitchen? Meet Mella Frewen, Suzy Renckens and Harry Kuiper: Three examples of how the industries take advantage of the European Food Safety Agency(EFSA) failure to properly regulate conflicts of interest.
In Bayer and the Global Compact, Phillipp Mimkes of the Coalition Against Bayer Dangers looks at Bayer's corporate history and why it may be at odds with the Compact, a partnership between the UN and big business. Here, Mimkes offers a few more reasons.